Alzheimer; News from the web:
Read all about it HERE
Alzheimer; News from the web:
Read all about it HERE
Alzheimer; News from the web:
WASHINGTON — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that.
Read all about it HERE
Alzheimer; News from the web:
The results of the clinical studies submitted by the drug’s manufacturer, Biogen, and the FDA’s accelerated approval, have been highly criticized by experts in the field.
Read all about it HERE
Alzheimer; News from the web:
The recent FDA approval of a new medicine for Alzheimer’s has still some questions about who is eligible to get it, the costs and more. Read the article in our link for today for some insights.
Read all about it HERE
Alzheimer; News from the web:
Truly great news today, the new drug Aducanumab has been approved by the FDA for use in early Alzheimer’s cases.
The drug was developed for patients with mild cognitive impairment, not severe dementia, and intended to slow progression of Alzheimer’s disease — not just ease symptoms.
Read all about it HERE
Alzheimer; News from the web:
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer’s disease rather than relieve symptoms.
But it’s unclear whether the Food and Drug Administration will approve the drug because of persistent questions about its effectiveness.
Read all about it HERE